Skip to search formSkip to main contentSkip to account menu

Hepatitis A Vaccine, Inactivated

Known as: Hepatitis A Vaccine Inactivated, HEPATITIS A, HEPATITIS A VACCINE (INACTIVATED) 
A vaccine used to prevent infection with the hepatitis A virus, which causes a serious liver disease. The vaccine is made of a weakened form of the… 
National Institutes of Health

Related topics

Related topics

11 relations
0.5 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Prefilled Syringe1 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Prefilled SyringeActively Acquired Immunity [PE]Drug Allergy

Narrower (1)

Vaqta

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review
Hepatitis A virus (HAV) is one of the most common infectious etiologies of acute hepatitis worldwide. The virus is known to be… 
Highly Cited
2003
Highly Cited
2003
Seroepidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease: Implications for HAV vaccination
Background: Universal vaccination against hepatitis A virus (HAV) has been recommended for children because of the changing… 
Highly Cited
2001
Highly Cited
2001
RAPID DECLINE OF ANTIBODIES AFTER HEPATITIS A IMMUNIZATION IN LIVER AND RENAL TRANSPLANT RECIPIENTS
Background. Hepatitis A vaccine is safe and achieves good seroconversion rates in liver (LTX) and renal (RTX) transplant… 
Highly Cited
2000
Highly Cited
2000
Hepatitis A and B in children and adolescents--what can we learn from Puglia (Italy) and Catalonia (Spain)?
Highly Cited
1996
Highly Cited
1996
Duration of protection from clinical hepatitis A disease after vaccination with VAQTA®
Recent papers examining the expected persistence of anti‐hepatitis A virus antibody following vaccination with inactivated… 
Highly Cited
1994
Highly Cited
1994
Interruption of an outbreak of hepatitis A in two villages by vaccination
During a large community‐wide outbreak of hepatitis A in two adjoining villages in Slovakia with a total of 5,000 inhabitants we… 
Highly Cited
1989
Highly Cited
1989
Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans.
Strain H2, an attenuated live hepatitis A virus (HAV), was derived from the fecal specimen of a patient with hepatitis A in… 
Highly Cited
1985
Highly Cited
1985
Molecular cloning and partial sequencing of hepatitis A viral cDNA
Hepatitis A virus was purified from infected monkey kidney cell cultures, and the viral RNA was used to synthesize double… 
Highly Cited
1985
Highly Cited
1985
Neutralizing antibody to hepatitis A virus in immune serum globulin and in the sera of human recipients of immune serum globulin.
Highly Cited
1978
Highly Cited
1978
An Inactivated Hepatitis A Virus Vaccine Prepared from Infected Marmoset Liver
Summary Human hepatitis A virus, partially purified from the liver of a rufiventer marmoset infected with CR326 strain virus, was… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)